The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Disease burden and long-term trends of urinary tract infections: A worldwide report
Open accessAbstract
Background: Urinary tract infections (UTIs) are one of the most common infections worldwide, but little is known about their global scale and long-term trends. We aimed to estimate the spatiotemporal patterns of UTIs' burden along with its attributable risk factors at a global level, as well as the variations of the burdens according to socio-demographic status, regions, nations, sexes, and ages, which may be helpful in guiding targeted prevention and treatment programs. Methods: Data from the Global Burden of Disease Study 2019 were analyzed to depict the incidence, mortality, and disability-adjusted life years (DALYs) of UTIs in 204 countries and territories from 1990 to 2019 by socio-demographic status, nations, region, sex, and age. Results: Globally, 404.61 million cases, 236,790 deaths, and 520,200 DALYs were estimated in 2019. In particular, 2.4 times growth in deaths from 1990 to 2019 was observed, along with an increasing age-standardized mortality rate (ASMR) from 2.77/100,000 to 3.13/100,000. Age-standardized incidence rate (ASIR) was consistently pronounced in regions with higher socio-demographic index (SDI), which presented remarkable upward trends in ASMR and age-standardized DALY rate (ASDR). In contrast, countries with a low SDI or high baseline burden achieved a notable decline in burden rates over the past three decades. Although the ASIR was 3.6-fold higher in females than males, there was no sex-based difference in ASMR and ASDR. The burden rate typically increased with age, and the annual increasing trend was more obvious for people over 60 years, especially in higher SDI regions. Conclusions: The burden of UTIs showed variations according to socio-demographic status, nation, region, sex, and age in the last three decades. The overall increasing burden intimates that proper prevention and treatment efforts should be strengthened, especially in high-income regions and aging societies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Murray, C. J. L., Aravkin, A. Y., Zheng, P., Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30752-2 · Cited by 9,854
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
Flores-Mireles, A. L., Walker, J. N., Caparon, M., & Hultgren, S. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3432 · Cited by 4,213
Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002
Klevens, R. M., Edwards, J. R., Richards, C. L., Horan, T. C., Gaynes, R. P., Pollock, D. A., & Cardo, D. M. (2007) · Public Health Reports® · doi:10.1177/003335490712200205 · Cited by 2,960
Guidelines for accurate and transparent health estimates reporting: the GATHER statement
Stevens, G. A., Alkema, L., Black, R. E., Boerma, J. T., Collins, G. S., Ezzati, M., Grove, J. T., Hogan, D. R., Hogan, M. C., Horton, R., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30388-9 · Cited by 1,798
Nicolle, L. E., Bradley, S., Colgan, R., Rice, J. C., Schaeffer, A., & Hooton, T. M. (2005) · Clinical Infectious Diseases · doi:10.1086/427507 · Cited by 1,601
Abrams, P., Andersson, K., Apostolidis, A., Birder, L., Bliss, D., Brubaker, L., Cardozo, L., Castro‐Diaz, D., O'Connell, P. R., Cottenden, A., et al. (2018) · Neurourology and Urodynamics · doi:10.1002/nau.23551 · Cited by 1,104
Abrams, P., Andersson, K. E., Birder, L., Brubaker, L., Cardozo, L., Chapple, C., Cottenden, A., Davila, W., de Ridder, D., Dmochowski, R., et al. (2010) · Neurourology and Urodynamics · doi:10.1002/nau.20870 · Cited by 1,098
Liu, Z., Jiang, Y., Yuan, H., Fang, Q., Cai, N., Suo, C., Jin, L., Zhang, T., & Chen, X. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.001 · Cited by 823
Scott, R. D. (2009) · Cited by 757
Yang, X., Fang, Y., Chen, H., Zhang, T., Yin, X., Man, J., Yang, L., & Lu, M. (2021) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796021000275 · Cited by 458
Self-citationGlobal epidemiology of urinary tract infections
Tandogdu, Z., & Wagenlehner, F. M. E. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000228 · Cited by 427
Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs
Betsy Foxman, B. (2003) · Disease-a-Month · doi:10.1016/s0011-5029(03)90000-9 · Cited by 418
UROLOGIC DISEASES IN AMERICA PROJECT: TRENDS IN RESOURCE USE FOR URINARY TRACT INFECTIONS IN MEN
GRIEBLING, T. L. (2005) · Journal of Urology · doi:10.1097/01.ju.0000155595.98120.8e · Cited by 351
Epidemiology of urological infections: a global burden
Öztürk, R., & Murt, A. (2020) · World Journal of Urology · doi:10.1007/s00345-019-03071-4 · Cited by 330
(2013) · doi:10.2217/ahe.13.38 · Cited by 321 · cited 3×
“Over-utilization of antimicrobial prescriptions increases the chances of development of multiple antimicrobial resistance caused by uropathogens and leads to more side effects (such as liver and renal damage and Clostridium difficile infection) (33).”
BackgroundGlobal burden for dengue and the evolving pattern in the past 30 years
Yang, X., Quam, M. B. M., Zhang, T., & Sang, S. (2021) · Journal of Travel Medicine · doi:10.1093/jtm/taab146 · Cited by 321
Self-citationNicolle, L. E. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00008-4 · Cited by 234
Urinary tract infections and Candida albicans
Behzadi, P., Behzadi, E., & Ranjbar, R. (2015) · Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication · doi:10.5173/ceju.2015.01.474 · Cited by 200
Agata, E. D., Loeb, M. B., & Mitchell, S. L. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12070 · Cited by 192
Yu, J., Yang, X., He, W., & Ye, W. (2021) · International Journal of Cancer · doi:10.1002/ijc.33617 · Cited by 177
Self-citationDiagnosis and Management of Urinary Tract Infections in the Outpatient Setting: A Review
Grigoryan, L., Trautner, B. W., & Gupta, K. (2014) · JAMA · doi:10.1001/jama.2014.12842 · Cited by 168
Potentially Inappropriate Treatment of Urinary Tract Infections in Two Rhode Island Nursing Homes
Rotjanapan, P., Dosa, D., & Thomas, K. S. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.13 · Cited by 168
Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection
Tal, S., Guller, V., Levi, S., Bardenstein, R., Berger, D., Gurevich, I., & Gurevich, A. (2005) · Journal of Infection · doi:10.1016/j.jinf.2004.04.004 · Cited by 162
Wagenlehner, F., Tandoğdu, Z., Bartoletti, R., Cai, T., Çek, M., Kulchavenya, E., Köves, B., Naber, K. G., Perepanova, T. S., Peter Tenke, A., et al. (2016) · Pathogens · doi:10.3390/pathogens5010010 · Cited by 104
Yang, X., Man, J., Chen, H., Zhang, T., Yin, X., He, Q., & Lü, M. (2020) · Lung Cancer · doi:10.1016/j.lungcan.2020.12.007 · Cited by 100
Self-citationYang, X., Zhang, T., Zhang, H., Sang, S., Chen, H., & Zuo, X. (2021) · Biomarker Research · doi:10.1186/s40364-021-00340-6 · Cited by 100
Self-citationAhmadi, M., Ranjbar, R., Behzadi, P., & Mohammadian, T. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2022.1990040 · Cited by 95
Clinical cases, drug resistance, and virulence genes profiling in Uropathogenic Escherichia coli
Hozzari, A., Behzadi, P., Kerishchi, P., Sholeh, M., & Sabokroo, N. (2020) · Journal of Applied Genetics · doi:10.1007/s13353-020-00542-y · Cited by 87
Alós, J.-I. (2005) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13091442 · Cited by 82
Juthani‐Mehta, M., & Quagliarello, V. (2010) · Clinical Infectious Diseases · doi:10.1086/656411 · Cited by 79
Rodhe, N. (2006) · Family Practice · doi:10.1093/fampra/cml007 · Cited by 55
Clinical Significance of Postvoid Residual Volume in Older Ambulatory Women
Huang, A. J., Brown, J. S., Boyko, E. J., Moore, E. E., Scholes, D., Walter, L. C., Lin, F., Vittinghoff, E., & Fihn, S. D. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03511.x · Cited by 49
Rebelo, M., Pereira, B. I., Lima, J., Decq-Mota, J., Vieira, J. D., & Costa, N. (2011) · International Archives of Medicine · doi:10.1186/1755-7682-4-33 · Cited by 48
de Miranda, É. J. P., de Oliveira, G. S. S., Roque, F. L., dos Santos, S. R., Olmos, R. D., & Lotufo, P. A. (2014) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652014000400009 · Cited by 36
Uropathogenic Escherichia coli: An Ideal Resource for DNA Microarray Probe Designing
Behzadi, P., & Behzadi, E. (2017) · Lecture notes in computer science · doi:10.1007/978-3-319-56154-7_2 · Cited by 33
Man, J., Zhang, T., Yin, X., Chen, H., Zhang, Y., Zhang, X., Chen, J., Yang, X., & Lü, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.800426 · Cited by 25
Self-citation
Cited by
The scope of the antimicrobial resistance challenge
Okeke, I. N., de Kraker, M. E. A., Van Boeckel, T. P., Kumar, C. K., Schmitt, H., Gales, A. C., Bertagnolio, S., Sharland, M., & Laxminarayan, R. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00876-6 · Cited by 474
Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics
Timm, M. R., Russell, S. K., & Hultgren, S. J. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01092-4 · Cited by 190
Metadata
- Authors
- Yang, X., Chen, H., Zheng, Y., Qu, S., Wang, H., & Yi, F.
- Venue
- Frontiers in Public Health
- Publisher
- Frontiers Media SA
- Published
- 2022-07-27
- Volume
- 10
- Pages
- 888205-888205
- ISSN
- 2296-2565 (ISSN-L)
- OpenAlex
- W4288033894
- Cited by
- 376
- References
- 37
- FWCI
- 41.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.